India-based Apollo Hospitals has announced plans to sell a 5%-6% stake in Apollo HealthCo, its healthcare platform, and raise approximately $200m in the current fiscal year, reported moneycontrol.com.

According to The Economic Times report, a top executive revealed that the hospital chain aims to sell the stake at an expected enterprise value of $2.5bn-$3bn.

In FY23, Apollo Hospitals reported revenues of Rs67.05bn ($814.58m) and incurred a loss of Rs3.04bn ($36.93m).

The offline pharmacy distribution business experienced a 31% year-on-year growth with Rs5.34bn ($64.88m) in earnings before interest, tax, depreciation, and amortisation (EBITDA), and the digital health business faced quarterly losses averaging around Rs1.8bn ($21.87m).

Apollo Hospitals expects an operational improvement in the financial year 2024, primarily driven by the goal of Apollo 24/7, the company’s omnichannel business, to reach EBITDA break-even by the fourth quarter.

During the quarter, the gross market value (GMV) of Apollo 24/7 reached Rs16.3bn ($198.03m), surpassing expectations of Rs15bn ($182.23m).

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Last month, Pfizer India and Apollo Hospital partnered to launch a Centre of Excellence (CoE) for adult vaccination in Hyderabad, India, as reported by The Economic Times.

The centre aims to increase vaccination rates by creating an ecosystem at Apollo Hospital to protect patients against vaccine-preventable diseases and will focus on educating healthcare professionals and patients about the benefits of vaccination.